ISMAEL
BUÑO BORDE
Profesor asociado
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (38)
2024
-
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12
2023
-
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
Transplantation and Cellular Therapy, Vol. 29, Núm. 7, pp. 472.e1-472.e4
-
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
Frontiers in Immunology, Vol. 14
-
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
Cancers, Vol. 15, Núm. 3
-
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567
-
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers, Vol. 15, Núm. 12
2022
-
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy
Transfusion, Vol. 62, Núm. 10, pp. 2143-2147
-
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
Frontiers in immunology, Vol. 13, pp. 1002959
-
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment (BMC Cancer, (2022), 22, 1, (982), 10.1186/s12885-022-10070-z)
BMC Cancer
-
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
BMC Cancer, Vol. 22, Núm. 1
-
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 16
-
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
Annals of Hematology, Vol. 101, Núm. 7, pp. 1567-1576
2021
-
Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma
Scientific Reports, Vol. 11, Núm. 1
-
Novel biallelic variant in BBS9 causative of Bardet–Biedl syndrome: expanding the spectrum of disease-causing genetic alterations
BMC Medical Genomics, Vol. 14, Núm. 1
2020
-
Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
Frontiers in Immunology, Vol. 11
-
Short tandem repeats (STRS) as biomarkers for the quantitative follow-up of chimerism after stem cell transplantation: Methodological considerations and clinical application
Genes, Vol. 11, Núm. 9, pp. 1-18
-
Variable selection with P-splines in functional linear regression: Application in graft-versus-host disease
Biometrical Journal, Vol. 62, Núm. 7, pp. 1670-1686
2019
-
Familial low phospholipid-associated cholelithiasis resulting from an autosomal dominant ABCB4 mutation
Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 10, pp. 806-808
-
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation
Blood Advances, Vol. 3, Núm. 21, pp. 3351-3359
-
Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation
Chemotherapy, Vol. 64, Núm. 2, pp. 57-61